Taking control: reorganization of the host cytoskeleton by Chlamydia. by Wesolowski, Jordan & Paumet, Fabienne
Thomas Jefferson University
Jefferson Digital Commons
Department of Microbiology and Immunology
Faculty Papers Department of Microbiology and Immunology
11-29-2017
Taking control: reorganization of the host
cytoskeleton by Chlamydia.
Jordan Wesolowski
Thomas Jefferson University, Jordan.Wesolowski@jefferson.edu
Fabienne Paumet
Thomas Jefferson University, Fabienne.Paumet@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/mifp
Part of the Medical Immunology Commons, and the Medical Microbiology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Microbiology and Immunology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Wesolowski, Jordan and Paumet, Fabienne, "Taking control: reorganization of the host cytoskeleton
by Chlamydia." (2017). Department of Microbiology and Immunology Faculty Papers. Paper 90.
https://jdc.jefferson.edu/mifp/90
 Open Peer Review
F1000 Faculty Reviews are commissioned
from members of the prestigious F1000
. In order to make these reviews asFaculty
comprehensive and accessible as possible,
peer review takes place before publication; the
referees are listed below, but their reports are
not formally published.
REVIEW
Taking control: reorganization of the host cytoskeleton by 
 Chlamydia [version 1; referees: 5 approved]
Jordan Wesolowski, Fabienne Paumet
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, 19107, USA
Abstract
Both actin and microtubules are major cytoskeletal elements in eukaryotic cells
that participate in many cellular processes, including cell division and motility,
vesicle and organelle movement, and the maintenance of cell shape. Inside its
host cell, the human pathogen  manipulates theChlamydia trachomatis 
cytoskeleton to promote its survival and enhance its pathogenicity. In particular,
 induces the drastic rearrangement of both actin and microtubules,Chlamydia
which is vital for its entry, inclusion structure and development, and host cell
exit. As significant progress in   genetics has greatly enhanced ourChlamydia
understanding of how this pathogen co-opts the host cytoskeleton, we will
discuss the machinery used by   to coordinate the reorganization ofChlamydia
actin and microtubules.
         Referee Status:
  Invited Referees
 version 1
published
29 Nov 2017
       1 2 3 4
5
, University ofRichard Hayward
Cambridge, UK
1
, University of Kentucky,Kenneth Fields
USA
2
, University of California,Joanne Engel
San Francisco, USA
3
, Max Planck Institute forThomas Meyer
Infection Biology, Germany
, Max Planck Institute forMunir Al-Zeer
Infection Biology, Germany
4
 29 Nov 2017,  (F1000 Faculty Rev):2058 (doi: First published: 6
)10.12688/f1000research.12316.1
 29 Nov 2017,  (F1000 Faculty Rev):2058 (doi: Latest published: 6
)10.12688/f1000research.12316.1
v1
Page 1 of 8
F1000Research 2017, 6(F1000 Faculty Rev):2058 Last updated: 01 DEC 2017
 Discuss this article
 (0)Comments
 Fabienne Paumet ( )Corresponding author: Fabienne.Paumet@jefferson.edu
  : Conceptualization, Methodology, Writing – Review & Editing;  : Conceptualization, Data Curation, FormalAuthor roles: Wesolowski J Paumet F
Analysis, Funding Acquisition, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing
 No competing interests were disclosed.Competing interests:
 Wesolowski J and Paumet F. How to cite this article: Taking control: reorganization of the host cytoskeleton by  [version 1;Chlamydia
   2017,  (F1000 Faculty Rev):2058 (doi:  )referees: 5 approved] F1000Research 6 10.12688/f1000research.12316.1
 © 2017 Wesolowski J and Paumet F. This is an open access article distributed under the terms of the Copyright: Creative Commons Attribution
, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Licence
 This work was supported by National Institutes of Health grant AI116983 to Fabienne Paumet Grant information:
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 29 Nov 2017,  (F1000 Faculty Rev):2058 (doi:  ) First published: 6 10.12688/f1000research.12316.1
, Washington StateRey Carabeo
University, USA
5
Page 2 of 8
F1000Research 2017, 6(F1000 Faculty Rev):2058 Last updated: 01 DEC 2017
Introduction
The Chlamydiaceae constitute a family of obligate intracellular 
bacteria that encompasses numerous species. With ~92 million 
new cases/year worldwide, Chlamydia trachomatis is the most 
frequent cause of bacterial sexually transmitted infections and 
is the leading cause of preventable infectious blindness called 
trachoma1–3. Trachoma is a significant problem in the develop-
ing world, where access to healthcare is limited and antibiotics 
are scarce. Chlamydia infections are also associated with chronic 
diseases and increased risk for cervical cancer4,5, making this 
infection a significant socioeconomic and medical burden in both 
developed and developing countries.
Chlamydiae exhibit a unique biphasic life cycle, cycling between 
a metabolically inactive but infectious small elementary body 
(EB ~200 nm) and a noninfectious metabolically active and divid-
ing large reticulate body (RB ~800 nm)6. Chlamydia spends the 
majority of its life as an intracellular RB. Soon after invasion, EBs 
differentiate into RBs and replicate within a membrane-bound 
compartment called an “inclusion”. This obligate intracellular 
lifestyle required Chlamydia to develop an effective strategy to 
manipulate host cell pathways in order to ensure its survival and 
replication. Among the many pathways that Chlamydia co-opts, a 
common and intriguing target for all Chlamydia species has emerged: 
the host cytoskeleton7. We will discuss the recent advances con-
cerning the role played by the host cytoskeleton in the growth and 
structural maintenance of the chlamydial inclusion (see Figure 1).
Chlamydia trachomatis recruits actin to enter its 
host cell and uses microtubules to travel to the 
microtubule-organizing center
Because of their obligate intracellular nature, Chlamydiae have 
evolved very efficient ways to enter eukaryotic cells (Figure 1A). 
During infection, EBs attach to the host cell surface via a relatively 
weak electrostatic interaction with heparan sulfate moieties8. Then 
a stronger and more specific binding to a cellular receptor takes 
place, during which the majority of the EBs are internalized via 
an actin-dependent event9. While a number of receptors have been 
identified, including PDGFR β, β1-integrin, and Ephrin A2, deple-
tion of a single receptor is not sufficient to block entry, suggesting 
that Chlamydia utilizes more than one receptor to invade its host 
cell10,11.
To promote entry into non-phagocytic epithelial cells, C. tracho-
matis delivers a translocated actin-recruiting phosphoprotein (Tarp, 
also known as CT456)12–14 into the host cytoplasm (Figure 1A). In a 
phosphorylation-dependent manner, Tarp recruits guanine nucleotide 
exchange factors that activate Rac1, a member of the Rho family of 
GTPases9,10,13,15. Whereas Chlamydia caviae uses both Rac1 and 
Cdc42 to promote its entry, C. trachomatis recruits only Rac1, and 
not Cdc42 or RhoA16,17. Hijacking only one Rho GTPase family 
member is unique to C. trachomatis, as other intracellular bacteria 
including Salmonella and Shigella usually use multiple isoforms 
such as RhoA and Cdc4218–20. In addition to its Rac1 recruitment 
function, Tarp also directly binds to actin monomers and nucleates 
new unbranched actin filaments21,22. These linear filaments are then 
branched via the host Arp2/3 complex, which is activated by the 
Rac1 signaling pathway9,13. Thus, Tarp functions as both an actin 
nucleator and a signaling platform to locally remodel the actin 
cytoskeleton and promote Chlamydia invasion.
Nascent C. trachomatis-containing inclusions then use the 
minus-end-directed microtubule motor dynein to move from the 
cell periphery to the microtubule-organizing center (MTOC), 
where the inclusion resides for the duration of the life cycle23 
(Figure 1B). This is a pathogen-driven event in which the inclu-
sion protein CT850 is involved through its interaction with 
the dynein light chain DYNLT124. At the MTOC, Src fam-
ily kinases control the tight association between inclusions and 
centrosomes25. Additional inclusion proteins including IncB, 
CT101, and CT222 are concentrated at these contact points 
between inclusions and centrosomes, suggesting their potential 
contribution to the transport of the inclusion24. In fact, during 
Chlamydia psittaci infection, IncB has been shown to interact 
with Snapin, which also binds dynein, thus connecting the inclu-
sion to the microtubule network26. The association of inclusions 
with the MTOC is a common characteristic for a number of 
Chlamydia species, suggesting that this event is essential for 
Chlamydia’s life cycle. One possibility is that the MTOC brings 
host organelles and chlamydial inclusions in close proximity, thus 
facilitating the transfer of nutrients and lipids from the host to 
the inclusion. Additionally, the clustering of the inclusions at the 
MTOC is necessary for the homotypic fusion of inclusions to 
take place during C. trachomatis infection, as the dissociation of 
the inclusions from the MTOC inhibits this fusion event27. Homo-
typic fusion is critical for C. trachomatis pathogenicity, as non- 
fusing mutants grow significantly slower than their wild-type 
counterparts28,29. In particular, C. trachomatis strains that do not 
undergo homotypic fusion are also replication-defective and cause 
significantly milder disease in humans28–30. Given the importance 
of microtubule-based transport of the inclusion in Chlamydia 
development, additional unidentified Chlamydia effectors are 
likely involved in this process.
Chlamydia creates microtubule cages to support the 
development of its inclusion
Around 12 hours post-infection (PI), microtubules likely assem-
ble around the inclusion under the control of the chlamydial 
effector CT223/IPAM, which has been shown to alter micro-
tubule organization through the host centrosomal protein of 
170 kDa (CEP170) in transfected cells31 (Figure 1C). There, micro-
tubules encasing the inclusion are stabilized, which allows them to 
undergo post-translational modifications (PTMs), including 
detyrosination and acetylation32,33 (Figure 1D). These PTMs influ-
ence microtubule structure and depolymerization rates34 and 
have been implicated in the relocation of the Golgi apparatus 
around the chlamydial inclusion32,33. In most cells, dynamic micro-
tubules have a half-life of about 5–10 minutes, while modified 
microtubules can persist for hours35, suggesting that Chlamydia 
uses these PTM microtubules to establish a stable long-term 
relationship with its host. Detyrosination is the best-characterized 
modification and involves the removal of the carboxy-terminal 
tyrosine from α-tubulin by tubulin carboxypeptidase, thus exposing 
a glutamic acid as the new C-terminus36.
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Figure 1. Reorganization of the host cytoskeleton during Chlamydia trachomatis infection. (A) Entry during which a translocated actin-
recruiting phosphoprotein (Tarp) induces actin polymerization; (B) transport of the nascent inclusion to the microtubule-organizing center 
(MTOC) using CT850; (C) formation of microtubule cages around the inclusion, in which CT223 is likely involved, and microtubule-dependent 
movement of lipid droplets (LDs) and multi-vesicular bodies (MVBs) towards the inclusion; (D) post-translational modifications of microtubule 
cages and positioning of Golgi mini-stacks around the inclusion controlled by CT813/InaC; (E) structural scaffolds of actin, septins, and 
intermediate filaments reinforce the growing inclusion membrane in a CT813-dependent manner; (F) Chlamydia exits the host cell using 
CT228-dependent extrusion (left) or through cell lysis (right).
Interestingly, stable microtubules are involved in the reposition-
ing of organelles. During infection, the Golgi is a major source 
of host lipids, including sphingomyelin and cholesterol37–40. 
To enhance access to these lipids, Chlamydia induces the frag-
mentation of the Golgi into mini-stacks, which are then recruited 
around the inclusion in a microtubule-dependent manner32,41 
(Figure 1D). In addition to controlling Golgi positioning, 
detyrosinated microtubules are involved in other trafficking 
events, including the recycling of endocytosed transferrin42 
and the dispersal of lipid droplets43, which are also co-opted 
by Chlamydia39,44. Lipid droplets and multi-vesicular bodies 
are redirected towards the chlamydial inclusion along microtu-
bules to provide fatty acids, which are important for Chlamydia 
replication39,40,44,45 (Figure 1C). The endoplasmic reticulum (ER) 
has also been associated with stable microtubules, in particular 
acetylated microtubules, along which ER tubules slide46. 
Chlamydia hijacks the ER and promotes the formation of 
ER-inclusion contact sites, which are important for the transfer 
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of  lipids to the inclusion47–49. During Chlamydia infection, the 
acetylated microtubules that surround the inclusion could enable 
the ER to slide towards the inclusion, thus allowing IncD/CERT 
to interact with the ER-resident proteins VAPA/VAPB and form 
ER-inclusion contact sites47,48. Although treatment with noco-
dazole, which disrupts microtubules, failed to prevent ER accu-
mulation around the inclusion49, acetylated microtubules are 
notoriously resistant to nocodazole treatment and may still be 
present following treatment.
Recently, we have shown that the chlamydial protein CT813 (also 
called InaC50) is critical for promoting microtubule modifica-
tions during infection through its interaction with and activation 
of the small host GTPases ARF1 and ARF433, supporting prior 
data showing interactions between CT813 and ARF proteins50 
(Figure 1D). It is unclear how the CT813:ARF complex is 
able to influence microtubule PTMs. However, inhibitors of 
RhoA and ROCK (Rho-associated protein kinase) decrease the 
number of inclusions associated with stable microtubules, sug-
gesting that both of these proteins are involved in this process32. 
There is evidence demonstrating that RhoA triggers microtubule 
stabilization via its interaction with the mammalian homolog of 
Diaphanous (mDia). The activation of mDia generates capped 
microtubules, thus preventing catastrophic microtubule 
disassembly51,52. Interestingly, DIAPH2 was identified in an 
RNAi screen in Drosophila S1 cells as important for chlamydial 
inclusion development10. It would be interesting to determine 
whether C. trachomatis co-opts mDia to stabilize microtubules 
and generate the post-translationally modified microtubule cages 
around the inclusion, particularly since mDia is also involved 
in actin polymerization53.
Chlamydia trachomatis builds actin scaffolds around 
its inclusion to promote inclusion stability
As the inclusion continues to grow, actin and intermediate fila-
ments associate with the inclusion54 (Figure 1E). This associa-
tion increases progressively from ~20 hours PI until the end of 
Chlamydia’s intracellular life cycle. Disruption of the actin 
cytoskeleton results in the rupture of the inclusion membrane and 
the leakage of C. trachomatis into the host cytoplasm, demon-
strating that the maintenance of the inclusion’s integrity requires 
intact actin cages54. Interestingly, RhoA—but not ROCK—also 
plays a major role in this event, as it is recruited to the inclusion 
and its depletion results in a substantial loss of actin scaffolds 
around the inclusion54.
The chlamydial protein CT813 is the only effector identified to 
date to regulate actin recruitment around the inclusion33,50 
(Figure 1E). Interestingly, this function of CT813 appears to be 
independent of its role in regulating post-translationally modi-
fied microtubule cages, as the overexpression of CT813 in wild-
type Chlamydia results in the loss of post-translationally modified 
microtubules but not actin cages33. Together, these data suggest 
that both CT813 and RhoA participate in actin cage formation 
and microtubule stabilization. While microtubule stabilization 
also depends on ARF1/ARF4 and ROCK, actin polymerization 
does not require ROCK. The role of ARF in the formation of actin 
cages remains unclear, as depletion of ARF does not affect actin 
polymerization33.
Recently, the actin cytoskeleton has been implicated in Golgi 
reorganization during infection. Using chemical mutagenesis, 
it has been suggested that CT813 organizes Golgi mini-stacks 
around the inclusion through the formation of actin cages50. 
However, a CT813-overexpressing Chlamydia strain that has 
actin but no post-translationally modified microtubule cages 
displays a defect in Golgi organization around the inclusion. 
This suggests that it is the CT813-dependent induction of post- 
translationally modified microtubule cages that controls Golgi 
organization33. Therefore, the exact role of the actin cytoskeleton 
in organelle repositioning during Chlamydia infection is still 
unclear.
Chlamydia uses the actin cytoskeleton to exit host 
cells by extrusion
Chlamydia exits the host cell through two mutually exclusive 
mechanisms: extrusion and cell lysis (Figure 1F, left and right, 
respectively). Note that to exit their host cells using the lytic 
process, Chlamydia must extricate themselves from the cytoskel-
eton structures that encase the inclusion, in particular the 
actin scaffold55. Pgp4, a transcription factor encoded by the 
chlamydial plasmid, is essential for actin depolymerization prior 
to cell exit, as the deletion of this regulatory gene prevents 
actin disassembly and completely blocks Chlamydia exit55. The 
chlamydial protease activity factor, which cleaves intermediate 
filaments, is also involved in cell exit, but it does not play a role in 
actin disassembly54–56.
While the lytic pathway requires actin depolymerization to 
proceed, extrusion is regulated by an acto-myosin-mediated 
mechanism57,58. Extrusion involves the protrusion of the intact 
membrane-bound inclusion out of the cell and the pinching 
off of the inclusion into a separate compartment. The result-
ing extruded inclusion is surrounded by the actin cytoskel-
eton59, the host plasma membrane, and a thin layer of cytoplasm 
between plasma and inclusion membranes57. Extrusion requires 
N-WASP-mediated actin polymerization and myosin II-depend-
ent contraction of stable actin filaments57,58. The septin family of 
cytoskeletal proteins regulates actin fiber formation on the inclu-
sion membrane60 through an unknown mechanism. Interestingly, 
RhoA is also involved in this process, where it specifically regu-
lates the final stage of extrusion—pinching off and separation of the 
extrusion from the host cell57.
The signals that dictate whether Chlamydia exits the host cell by 
lysis or extrusion are not well understood. However, the Chlamy-
dial inclusion protein CT228 has been shown to play a central 
role in this process58. CT228 recruits the MYPTI subunit of myosin 
phosphatase to microdomains on the inclusion membrane early 
during infection. MYPTI-mediated phosphorylation of myosin 
light chain II (MLC2) favors extrusion-mediated exit, while 
the depletion or dephosphorylation of MLC2 shifts the balance 
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towards the lytic pathway. Thus, Chlamydia establishes local 
cytoskeletal signaling networks on the inclusion membrane to 
direct its escape from the host cell.
Concluding remarks
Chlamydia has evolved efficient mechanisms to hijack essential 
components of the host cytoskeleton. The successful estab-
lishment of Chlamydia’s intracellular niche and dissemination 
of infectious progeny relies on the proper spatial and tempo-
ral control of both actin and microtubules. To orchestrate this 
balance, Chlamydia employs effector proteins to recruit host 
proteins to the inclusion membrane and modulate the activity of 
host cytoskeletal signaling networks. Recent work has only begun 
to shed light on the identity of these chlamydial effector proteins.
Almost a decade ago, an RNAi screen in C. trachomatis- 
infected Drosophila cells revealed the importance of numerous 
host cytoskeleton-associated proteins in inclusion development, 
supporting the critical role of the cytoskeleton during infection10. 
However, limited mechanistic information regarding the role 
of chlamydial effector proteins in this process was available 
owing to the intractability of Chlamydia to genetic manipulation. 
Recent advances in Chlamydia genetics and the expansion of the 
Chlamydia genetic toolbox now provide the tools necessary to 
dissect the molecular pathways and the chlamydial effectors that 
control the interactions between the chlamydial inclusion and the 
host cytoskeleton. Identifying these mechanisms is important not 
only for understanding Chlamydia pathogenesis and developing 
novel therapeutics but also because it has the potential to identify 
new host cellular pathways that regulate the cytoskeleton.
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